| Announce Date | 12/12/2024 |
| EPS Normalized Actual | $-0.27266 (Miss by $-0.15266) |
| EPS GAAP Actual | $-0.27266 (Miss by $-0.15266) |
| Revenue Actual | $0.0001B |
| Revenue Surprise | Beat by $0.1M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.01 |
| EPS GAAP Estimate | $-0.01 |
| Revenue Estimate | $0.04845525B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Apr 2029 | 0 | INF | 0 | 0 | 1 |
| Apr 2029 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 1994 (Oct 1994) | -3.85 | -3.85 | 0.0001B | 100% | 0.1M |
| FQ1 1995 (Jan 1995) | -3.85 | -3.85 | 0.0001B | 100% | 0.1M |
| FQ2 1995 (Apr 1995) | -4.08 | -4.08 | 0B | NAN% | 0M |
| FQ4 2024 (Oct 2024) | -0.27 | -0.27 | 0.033482B | 24.15% | 33.48M |
| FQ3 2024 (Jul 2024) | -0.087 | -0.087 | 0.040173B | 6.09% | 40.17M |
| FQ2 2024 (Apr 2024) | -1.94 | -1.94 | 0.042975B | 7.39% | 42.98M |
| FQ1 2024 (Jan 2024) | -0.0949 | -0.0949 | 0.033815B | -12.43% | 33.82M |
| FQ4 2023 (Oct 2023) | -0.15 | -0.15 | 0.025395B | -36.87% | 25.4M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.01
Consensus Revenue Estimates
0.04845525B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (May 2027) | 0 | -- | 0 | 0 | 0 |
| FQ1 2027 (Jan 2027) | 0 | -- | 0 | 0 | 1 |
| FQ4 2026 (Oct 2026) | 0 | -- | 0 | 0 | 1 |
| FQ3 2026 (Jul 2026) | 0 | -- | 0 | 0 | 1 |
| FQ2 2026 (May 2026) | 0.08 | -- | 0.076037 | 0.08178271 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (May 2027) | 0.06B | -- | 0.06B | 0.07B | 1 |
| FQ1 2027 (Jan 2027) | 0.05B | -- | 0.05B | 0.06B | 2 |
| FQ4 2026 (Oct 2026) | 0.05B | -- | 0.05B | 0.05B | 2 |
| FQ3 2026 (Jul 2026) | 0.05B | -- | 0.05B | 0.06B | 2 |
| FQ2 2026 (May 2026) | 0.06B | -- | 0.06B | 0.06B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 1994 (Oct 1994) | -3.85 | -3.85 | 100% | |
| FQ1 1995 (Jan 1995) | -3.85 | -3.85 | 100% | |
| FQ2 1995 (Apr 1995) | -4.08 | -4.08 | 100% | |
| FQ4 2024 (Oct 2024) | -0.27 | -0.27 | 100% | |
| FQ3 2024 (Jul 2024) | -0.087 | -0.087 | 100% | |
| FQ2 2024 (Apr 2024) | -1.94 | -1.94 | 100% | |
| FQ1 2024 (Jan 2024) | -0.0949 | -0.0949 | 100% | |
| FQ4 2023 (Oct 2023) | -0.15 | -0.15 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 1994 (Oct 1994) | $0B | $0B | $0.1M | 100% |
| FQ1 1995 (Jan 1995) | $0B | $0B | $0.1M | 100% |
| FQ2 1995 (Apr 1995) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Oct 2024) | $0B | $0.03B | $33.48M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.04B | $40.17M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.04B | $42.98M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.03B | $33.82M | 100% |
| FQ4 2023 (Oct 2023) | $0B | $0.03B | $25.4M | 100% |